Ciprofibrate EP Impurity A

Stability-indicating liquid chromatographic and UV spectrophotometric methods for the quantification of ciprofibrate in capsules and tablets
Fernanda Macke Hellwig, Rafael Henrique Dias Reis, Suzana Del Rosso Barbosa, Marcelo Donadel Malesuik
Braz. J. Pharm. Sci. vol.51 no.1 São Paulo Jan./Mar. 2015
 
Differential pulse voltammetric determination of ciprofibrate in pharmaceutical formulations using a glassy carbon electrode modified with functionalized carbon nanotubes within a poly(allylamine hydrochloride) film
Humberto H. Takedaa,b,c, Bruno C. Janegitz a, Roberta A. Medeiros a, Luiz H.C. Mattoso b, Orlando Fatibello-Filho
Sensors and Actuators B 161 (2012) 755–760

Ciprofibrate EP Impurity A is chemically 2-(4-Ethenylphenoxy)-2-methylpropanoic acid. Ciprofibrate EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Ciprofibrate EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ciprofibrate.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.